It also displayed similar potency on DYRK kinases (DYRK1A and DYRK1B), which is particularly interesting as this might have a beneficial effect in Alzheimer’s disease, given the role of DYRK in tau and Aβ formation [53,54]. Here, DYRK1A is linked to early-onset autosomal dominant Alzheimer disease.